| answer text |
<p>The United Kingdom left the European Union on 31 January and is now in a Transition
Period until 31 December 2020. During this time, it remains our objective to negotiate
a future relationship with the EU and in our respective published negotiating documents,
we have both stated objectives to reach an agreement on trade in goods. The UK’s published
approach sets out how we want to facilitate trade in medicinal products and support
high levels of patient safety.</p><p>The Government, pharmaceutical industry and National
Health Service will always work closely together to help ensure patients continue
to have access, to the medicines and treatments they need, including insulin, under
all scenarios.</p><p>The Department has well-established procedures to deal with medicine
shortages and is working closely with industry, the NHS and others in the supply chain
to reduce the likelihood of future shortages resulting from any cause.</p><p> </p>
|
 |
